1、ANNUAL REPORT2023 2023 年報年報ANNUAL REPORT 20237MM MOVED?7MM MOVEDPIONEERING GLOBALREGENERATIVESCIENCE&TECHNOLOGYESSEX BIO-TECHNOLOGY LIMITEDii TOMORROWS TODAYAnnual Report 20231CONTENTS Contents2Chairmans Statement10Business Review20Financial Highlights21Financial Review28Profiles of Directors and Se
2、nior Management31Report of the Directors54Independent Auditors Report58Consolidated Statement of Profit or Loss andOther Comprehensive Income59Consolidated Statement of Financial Position 60Consolidated Statement of Changes in Equity61Consolidated Statement of Cash Flows63Notes to the Consolidated F
3、inancial Statements122Five Year Financial Summary123Corporate Governance Report136Corporate InformationContents CHAIRMANS STATEMENTNgiam Mia Je PatrickChairmanCHAIRMANS STATEMENT CHAIRMANS STATEMENT3Annual Report 2023On behalf of the board of directors(the“Board”)of Essex Bio-Technology Limited(the“
4、Company”,together with its subsidiaries,the“Group”),it is our pleasure to present to you the performances for the financial year ended 31 December 2023.In 2023,we bid farewell to COVID-19 pandemic that has lasted for three years(2020 to 2022),took off our masks,and gradually returned to the work-lif
5、e and social-life conditions we were familiar with in the past.However,the expected comprehensive economic recovery did not come as promised,and the macroeconomic environment is still full of uncertainties.Against the backdrop of the Federal Reserves continued interest rate hikes,the escalation of t
6、he Sino-US trade war,the Russia-Ukraine conflict,and the Palestinian-Israeli conflict,it is considered that the global economy is still in a turbulent state.During the past year,Peoples Republic of China(the“PRC”),the worlds second-largest economy,saw some of its slowest growth in decades as a debt